Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Radiotherapy × 30 days × Clear all

Sponsor

Conditions

Glioblastoma 12 Prostatic Neoplasms 10 Lung Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Breast Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 7 Glioma 7 Uterine Cervical Neoplasms 5 Head and Neck Neoplasms 5 Astrocytoma 5 Urinary Bladder Neoplasms 4 Sarcoma 4 Oropharyngeal Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Radiation Injuries 3 Carcinoma 3 Vaginal Neoplasms 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Lymphoma, Follicular 2 Liposarcoma 2 Leiomyosarcoma 2

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡